Challenges in Defining Predictive Markers for Response to Endocrine Therapy in Breast Cancer

• Beatson GT : On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases.Lancet2, 104–107 (1896).
   Google Scholar
• Musgrove EA , SutherlandRL: Biological determinants of endocrine resistance in breast cancer.Nat. Rev. Cancer9, 631–643 (2009).
   PubMed Web of Science ®Google Scholar
• Miller WR , O’NeillJ: The importance of local synthesis of estrogen within the breast.Steroids50(4–6), 537–548 (1987).
   PubMedGoogle Scholar
• Grodin JM , SiiteriPK, MacDonaldPC: Source of estrogen production in postmenopausal women.J. Clin. Endocrinol. Metab.36(2), 207–214 (1973).
   PubMed Web of Science ®Google Scholar
• Miller WR : Prediction of estrogen sensitivity/dependence. In: Estrogen and breast cancer. Miller WR (Ed.). R.G. Landes Co., TX, USA, 151–170 (1996).
   Google Scholar
• Dixon JM : Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.Expert Rev. Anticancer Ther.8(3), 453–463 (2008).
   PubMed Web of Science ®Google Scholar
• Kaufmann M , von MinckwitzG, BearHDet al.: Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.Ann. Oncol.18(12), 1927–1934 (2007).
   PubMed Web of Science ®Google Scholar
• Ma CX , EllisMJ: Neoadjuvant endocrine therapy for locally advanced breast cancer.Semin. Oncol.33(6), 650–656 (2006).
   PubMed Web of Science ®Google Scholar
• Murray J , MillerWR, DixonJM: Neoadjuvant endocrine therapy models.Methods Mol. Med.120, 489–502 (2006).
   PubMedGoogle Scholar
• Macaskill EJ , DixonJM: Neoadjuvant use of endocrine therapy in breast cancer.Breast J.13(3), 243–250 (2007).
   PubMed Web of Science ®Google Scholar
• Miller WR , LarionovA, RenshawLet al.: Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole.J. Clin. Oncol.27(9), 1382–1387 (2009).
   PubMed Web of Science ®Google Scholar
• Miller WR , LarionovAA, RenshawLet al.: Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole.Pharmacogenet. Genomics17(10), 813–826 (2007).
   PubMed Web of Science ®Google Scholar
• Ellis MJ , TaoY, LuoJet al.: Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.J. Natl Cancer Inst.100(19), 1380–1388 (2008).
   PubMedGoogle Scholar
• Dixon JM : The scientific value of preoperative studies and how they can be used.Breast Cancer Res. Treat.87(Suppl. 1), S19–S26 (2004).
   PubMedGoogle Scholar
• Iqbal S , AndersonTJ, MarsonLP, PrescottRJ, DixonJM, MillerWR: MIB-1 assessments in breast cancers.Breast11(3), 252–256 (2002).
   PubMed Web of Science ®Google Scholar
• Dixon JM : Neoadjuvant therapy: surgical perspectives. In: Endocrine Therapy in Breast Cancer. MillerWR, IngleJN (Eds). Marcel Dekker, NY, USA, 197–212 (2002).
   Google Scholar
• Ma CX , SanchezCG, EllisMJ: Predicting endocrine therapy responsiveness in breast cancer.Oncology (Williston Park)23(2), 133–142 (2009).
   PubMed Web of Science ®Google Scholar
• Dowsett M , SmithIE, EbbsSRet al.: Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.Clin. Cancer Res.11(2 Pt 2), S951–S958 (2005).
   PubMed Web of Science ®Google Scholar
• Forouhi P , WalshJS, AndersonTJ, ChettyU: Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment.Br. J. Surg.81(2), 223–225 (1994).
   PubMed Web of Science ®Google Scholar
• Kuerer HM , NewmanLA, SmithTLet al.: Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.J. Clin. Oncol.17(2), 460–469 (1999).
   PubMed Web of Science ®Google Scholar
• Dixon JM , LoveCD, RenshawLet al.: Lessons from the use of aromatase inhibitors in the neoadjuvant setting.Endocr. Relat. Cancer6(2), 227–230 (1999).
   PubMed Web of Science ®Google Scholar
• Sasano H , SuzukiT, MoriyaT: Pathology of breast cancer following neoadjuvant therapy. In: Endocrine Therapy in Breast Cancer. MillerWR, IngleJN (Eds). Marcel Dekker, NY, USA, 213–222 (2002).
   Google Scholar
• Anderson TJ , DixonJM, StuartM, SahmoudT, MillerWR: Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer.Br. J. Cancer87(3), 334–338 (2002).
   PubMed Web of Science ®Google Scholar
• Miller WR , DixonJM, MacFarlaneL, CameronD, AndersonTJ: Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen.Eur. J. Cancer39(4), 462–468 (2003).
   PubMed Web of Science ®Google Scholar
• Miller WR , DixonJM, CameronDA, AndersonTJ: Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy.J. Steroid Biochem. Mol. Biol.79(1–5), 103–107 (2001).
   PubMed Web of Science ®Google Scholar
• Miller WR , WhiteS, DixonJM, MurrayJ, RenshawL, AndersonTJ: Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole.Br. J. Cancer94(7), 1051–1056 (2006).
   PubMed Web of Science ®Google Scholar
• Tao Y , KlauseA, VickersA, BaeK, EllisM: Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials.J. Steroid Biochem. Mol. Biol.95(1–5), 91–95 (2005).
   PubMed Web of Science ®Google Scholar
• Ellis MJ , CoopA, SinghBet al.: Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a Phase III randomized trial.J. Clin. Oncol.19(18), 3808–3816 (2001).
   PubMed Web of Science ®Google Scholar
• Mackay A , UrruticoecheaA, DixonJMet al.: Molecular response to aromatase inhibitor treatment in primary breast cancer.Breast Cancer Res.9(3), R37 (2007).
   PubMed Web of Science ®Google Scholar
• Cappelletti V , GariboldiM, De CeccoLet al.: Patterns and changes in gene expression following neo-adjuvant antiestrogen treatment in estrogen receptor-positive breast cancer.Endocr. Relat. Cancer15(2), 439–449 (2008).
   PubMed Web of Science ®Google Scholar
• Dowsett M , SalterJ, HillsM, DetreS, A’HernR, SmithIE: Short-term presurgical treatment for all?Breast Cancer Res.9(Suppl. 2), S13 (2007).
   Google Scholar
• Gonzalez-Angulo AM , Morales-VasquezF, HortobagyiGN: Overview of resistance to systemic therapy in patients with breast cancer.Adv. Exp. Med. Biol.608, 1–22 (2007).
   PubMed Web of Science ®Google Scholar
• Miller WR , AndersonTJ, IqbalS, DixonJM: Neoadjuvant therapy: prediction of response. In: Endocrine Therapy in Breast Cancer. MillerWR, IngleJN (Eds). Marcel Dekker, NY, USA, 223–229 (2002).
   Google Scholar
• Elledge RM , GreenS, PughRet al.: Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.Int. J. Cancer89(2), 111–117 (2000).
   PubMed Web of Science ®Google Scholar
• Ravdin PM , GreenS, DorrTMet al.: Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.J. Clin. Oncol.10(8), 1284–1291 (1992).
   PubMed Web of Science ®Google Scholar
• Dowsett M , HoughtonJ, IdenCet al.: Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.Ann. Oncol.17(5), 818–826 (2006).
   PubMed Web of Science ®Google Scholar
• Wright C , NicholsonS, AngusBet al.: Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.Br. J. Cancer65(1), 118–121 (1992).
   PubMed Web of Science ®Google Scholar
• Lal P , TanLK, ChenB: Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas.Am. J. Clin. Pathol.123(4), 541–546 (2005).
   PubMed Web of Science ®Google Scholar
• Leyland-Jones BR , AmbrosoneCB, BartlettJet al.: Recommendations for collection and handling of specimens from group breast cancer clinical trials.J. Clin. Oncol.26(34), 5638–5644 (2008).
   PubMed Web of Science ®Google Scholar
• Medeiros F , RiglCT, AndersonGG, BeckerSH, HallingKC: Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities.Arch. Pathol. Lab. Med.131(12), 1805–1816 (2007).
   PubMed Web of Science ®Google Scholar
• Koch I , Slotta-HuspeninaJ, HollweckRet al.: Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues.Diagn. Mol. Pathol.15(3), 149–156 (2006).
   PubMedGoogle Scholar
• Madabusi LV , LathamGJ, AndrussBF: RNA extraction for arrays.Methods Enzymol.411, 1–14 (2006).
   PubMed Web of Science ®Google Scholar
• Hewitt SM , LewisFA, CaoYet al.: Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue.Arch. Pathol. Lab. Med.132(12), 1929–1935 (2008).
   PubMed Web of Science ®Google Scholar
• Esposito G : Complementary techniques: laser capture microdissection – increasing specificity of gene expression profiling of cancer specimens.Adv. Exp. Med. Biol.593, 54–65 (2007).
   PubMed Web of Science ®Google Scholar
• Jansen MP , FoekensJA, van StaverenILet al.: Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling.J. Clin. Oncol.23(4), 732–740 (2005).
   PubMed Web of Science ®Google Scholar
• Nygaard V , HoldenM, LolandA, LangaasM, MyklebostO, HovigE: Limitations of mRNA amplification from small-size cell samples.BMC Genomics6, 147 (2005).
   PubMed Web of Science ®Google Scholar
• Nygaard V , HovigE: Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling.Nucleic Acids Res.34(3), 996–1014 (2006).
   PubMed Web of Science ®Google Scholar
• Zahringer H : Product survey: DNA/RNA isolation. Spoilt for choice.Lab Times5, 50–58 (2007).
   Google Scholar
• Ambion AB : mirVana™ miRNA Isolation Kit – Instruction Manual (2008).
   Google Scholar
• Qiagen : miRNeasy Mini Handbook (2007).
   Google Scholar
• Schroeder A , MuellerO, StockerSet al.: The RIN: an RNA integrity number for assigning integrity values to RNA measurements.BMC Mol. Biol.7, 3 (2006).
   PubMed Web of Science ®Google Scholar
• Strand C , EnellJ, HedenfalkI, FernoM: RNA quality in frozen breast cancer samples and the influence on gene expression analysis – a comparison of three evaluation methods using microcapillary electrophoresis traces.BMC Mol. Biol.8, 38 (2007).
   PubMed Web of Science ®Google Scholar
• Egyhazi S , BjohleJ, SkoogLet al.: Proteinase K added to the extraction procedure markedly increases RNA yield from primary breast tumors for use in microarray studies.Clin. Chem.50(5), 975–976 (2004).
   PubMed Web of Science ®Google Scholar
• Finke J , FritzenR, TernesP, LangeW, DolkenG: An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR.Biotechniques14(3), 448–453 (1993).
   PubMed Web of Science ®Google Scholar
• Markoulatos P , SiafakasN, MoncanyM: Multiplex polymerase chain reaction: a practical approach.J. Clin. Lab. Anal.16(1), 47–51 (2002).
   PubMed Web of Science ®Google Scholar
• Brenan CJ , RobertsD, HurleyJ: Nanoliter high-throughput PCR for DNA and RNA profiling.Methods Mol. Biol.496, 161–174 (2009).
   PubMedGoogle Scholar
• Chagovetz A , BlairS: Real-time DNA microarrays: reality check.Biochem. Soc. Trans.37(Pt 2), 471–475 (2009).
   PubMedGoogle Scholar
• Chiorino G , Mello GrandM, ScatoliniM, OstanoP: From single gene to integrative molecular concept MAPS: pitfalls and potentials of microarray technology.J. Biol. Regul. Homeost. Agents22(1), 7–16 (2008).
   PubMed Web of Science ®Google Scholar
• Wang Y , BarbacioruC, HylandFet al.: Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.BMC Genomics7, 59 (2006).
   PubMed Web of Science ®Google Scholar
• Branham WS , MelvinCD, HanTet al.: Elimination of laboratory ozone leads to a dramatic improvement in the reproducibility of microarray gene expression measurements.BMC Biotechnol.7, 8 (2007).
   PubMed Web of Science ®Google Scholar
• Shi L , ReidLH, JonesWDet al.: The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.Nat. Biotechnol.24(9), 1151–1161 (2006).
   PubMed Web of Science ®Google Scholar
• Arikawa E , SunY, WangJet al.: Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study.BMC Genomics9, 328 (2008).
   PubMed Web of Science ®Google Scholar
• Kubista M , AndradeJM, BengtssonMet al.: The real-time polymerase chain reaction.Mol. Aspects Med.27(2–3), 95–125 (2006).
   PubMedGoogle Scholar
• Brentani RR , CarraroDM, Verjovski-AlmeidaSet al.: Gene expression arrays in cancer research: methods and applications.Crit. Rev. Oncol. Hematol.54(2), 95–105 (2005).
   PubMed Web of Science ®Google Scholar
• Allison DB , CuiX, PageGP, SabripourM: Microarray data analysis: from disarray to consolidation and consensus.Nat. Rev. Genet.7(1), 55–65 (2006).
   PubMed Web of Science ®Google Scholar
• Sasik R , WoelkCH, CorbeilJ: Microarray truths and consequences.J. Mol. Endocrinol.33(1), 1–9 (2004).
   PubMed Web of Science ®Google Scholar
• Timlin JA : Scanning microarrays: current methods and future directions.Methods Enzymol.411, 79–98 (2006).
   PubMed Web of Science ®Google Scholar
• Barbacioru CC , WangY, CanalesRDet al.: Effect of various normalization methods on Applied Biosystems expression array system data.BMC Bioinformatics7, 533 (2006).
   PubMed Web of Science ®Google Scholar
• Werner T : Bioinformatics applications for pathway analysis of microarray data.Curr. Opin. Biotechnol.19(1), 50–54 (2008).
   PubMed Web of Science ®Google Scholar
• Rice TK , SchorkNJ, RaoDC: Methods for handling multiple testing.Adv. Genet.60, 293–308 (2008).
   PubMed Web of Science ®Google Scholar
• Simon R , RadmacherMD, DobbinK, McShaneLM: Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.J. Natl Cancer Inst.95(1), 14–18 (2003).
   PubMedGoogle Scholar
• Ransohoff DF : Rules of evidence for cancer molecular-marker discovery and validation.Nat. Rev. Cancer4(4), 309–314 (2004).
   PubMed Web of Science ®Google Scholar
• Taylor JM , AnkerstDP, AndridgeRR: Validation of biomarker-based risk prediction models.Clin. Cancer Res.14(19), 5977–5983 (2008).
   PubMed Web of Science ®Google Scholar
• Molinaro AM , SimonR, PfeifferRM: Prediction error estimation: a comparison of resampling methods.Bioinformatics21(15), 3301–3307 (2005).
   PubMed Web of Science ®Google Scholar
• Desmedt C , Ruiz-GarciaE, AndreF: Gene expression predictors in breast cancer: current status, limitations and perspectives.Eur. J. Cancer44(18), 2714–2720 (2008).
   PubMed Web of Science ®Google Scholar
• Bartels CL , TsongalisGJ: MicroRNAs: novel biomarkers for human cancer.Clin. Chem.55(4), 623–631 (2009).
   PubMed Web of Science ®Google Scholar
• Lopez J , PerchardeM, ColeyHM, WebbA, CrookT: The context and potential of epigenetics in oncology.Br. J. Cancer100(4), 571–577 (2009).
   PubMed Web of Science ®Google Scholar
• Tan DS , Reis-FilhoJS: Comparative genomic hybridisation arrays: high-throughput tools to determine targeted therapy in breast cancer.Pathobiology75(2), 63–74 (2008).
   PubMed Web of Science ®Google Scholar
• Tyson DR , OrnsteinDK: Proteomics of cancer of hormone-dependent tissues.Adv. Exp. Med. Biol.630, 133–147 (2008).
   PubMed Web of Science ®Google Scholar
• Voelkerding KV , DamesSA, DurtschiJD: Next-generation sequencing: from basic research to diagnostics.Clin. Chem.55(4), 641–658 (2009).
   PubMed Web of Science ®Google Scholar
• Wang Z , GersteinM, SnyderM: RNA-Seq: a revolutionary tool for transcriptomics.Nat. Rev. Genet.10(1), 57–63 (2009).
   PubMed Web of Science ®Google Scholar
• Sparano JA , PaikS: Development of the 21-gene assay and its application in clinical practice and clinical trials.J. Clin. Oncol.26(5), 721–728 (2008).
   PubMed Web of Science ®Google Scholar
• Buyse M , LoiS, van’t VeerLet al.: Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.J. Natl Cancer Inst.98(17), 1183–1192 (2006).
   PubMed Web of Science ®Google Scholar
• Miller WR , LarionovA, AndersonTJet al.: Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors.Cancer112(3 Suppl.), 689–694 (2008).
   PubMed Web of Science ®Google Scholar
• Kato K : Algorithm for in vitro diagnostic multivariate index assay.Breast Cancer16(4), 248–251 (2009).
   PubMed Web of Science ®Google Scholar
• Simon R : Roadmap for developing and validating therapeutically relevant genomic classifiers.J. Clin. Oncol.23(29), 7332–7341 (2005).
   PubMed Web of Science ®Google Scholar
• Berg AO , ArmstrongK, BotkinJet al.: Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?Genet. Med.11(1), 66–73 (2009).
   PubMed Web of Science ®Google Scholar
• Ioannidis JP : Is molecular profiling ready for use in clinical decision making?Oncologist12(3), 301–311 (2007).
   PubMed Web of Science ®Google Scholar

Websites

• Free software environment for statistical computing and graphics www.R-project.org
   Google Scholar
• Open source and open development software project for analysis of genomic data www.bioconductor.org
   Google Scholar
• Controlled vocabulary describing genes in terms of biological processes, molecular functions and cellular locations of their products www.geneontology.org
   Google Scholar